top of page
  • Writer's pictureBioluminux

Approved Pharmaceutical Medicine Specialty Training Site

Updated: Jun 16

The General Medical Council (GMC) approved Bioluminux Clinical Research Site in the UK as a training site for the Pharmaceutical Medicine Specialty Training programme (PMST) in December 2021. The PMST programme is an accredited Higher Specialty training for Pharmaceutical Physicians, who are equipped with specialist knowledge and capabilities to practice in the development and maintenance of medicines. Those that completes the programme will be registered as Specialist in Pharmaceutical Medicine by the GMC. For further information on the PMST programme, kindly visit

30 views0 comments


bottom of page